IMAX Stock - IMAX Corporation
Unlock GoAI Insights for IMAX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $352.21M | $374.84M | $300.81M | $254.88M | $137.00M |
| Gross Profit | $190.20M | $214.34M | $156.35M | $134.41M | $21.54M |
| Gross Margin | 54.0% | 57.2% | 52.0% | 52.7% | 15.7% |
| Operating Income | $43.86M | $50.40M | $-4,834,000 | $10.98M | $-121,821,000 |
| Net Income | $26.06M | $25.34M | $-22,800,000 | $-22,329,000 | $-143,775,000 |
| Net Margin | 7.4% | 6.8% | -7.6% | -8.8% | -104.9% |
| EPS | $0.49 | $0.47 | $-0.40 | $-0.38 | $-2.43 |
IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company worldwide. It offers cinematic solution through proprietary software, theater architecture, intellectual property, and specialized equipment. The company offers IMAX Digital Re-Mastering (DMR), a proprietary technology that digitally enhances the image resolution, visual clarity, and sound quality of motion picture films for projection on IMAX screens; IMAX theater systems to exhibitor customers through sales, leases, and joint revenue sharing arrangements; and digital projection systems. It also provides preventative and emergency maintenance services to IMAX network; distributes large-format documentary films; film post-production and quality control services for large-format films, and digital post-production services; owns and operates IMAX theaters; and rents 2D and 3D large-format film and digital cameras, as well as offers production advice and technical assistance services to documentary and Hollywood filmmakers. The company markets its theater systems through a direct sales force and marketing staff to science and natural history museums, zoos, aquaria, and other educational and cultural centers, as well as theme parks, private home theaters, tourist destination sites, fairs, and expositions. It owns or otherwise has rights to trademarks and trade names, which include IMAX, IMAX Dome, IMAX 3D, IMAX 3D Dome, Experience It in IMAX, The IMAX Experience, An IMAX Experience, An IMAX 3D Experience, IMAX DMR, DMR, IMAX Enhanced, IMAX nXos, and Films To The Fullest. As of December 31, 2021, the company had a network of 1,683 IMAX theater systems comprising 1,599 commercial multiplexes, 12 commercial destinations, and 72 institutional facilities operating in 87 countries and territories. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 15th 2025 | JP Morgan | Upgrade | Overweight | $47 |
| November 25th 2025 | Goldman | Upgrade | Neutral | $34 |
| May 16th 2025 | B. Riley Securities | Resumed | Buy | $36 |
| July 24th 2024 | Seaport Research Partners | Initiation | Buy | $23 |
| April 21st 2023 | Barrington Research | Reiterated | Outperform | $24← $22 |
| December 5th 2022 | B. Riley Securities | Reiterated | Buy | $23← $20 |
| October 12th 2022 | B. Riley Securities | Reiterated | Buy | $20← $25 |
| May 24th 2022 | Rosenblatt | Initiation | Buy | $25 |
Earnings History & Surprises
IMAXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q1 2026 | Feb 18, 2026 | $0.42 | — | — | — |
Q4 2025 | Oct 23, 2025 | $0.35 | $0.47 | +34.1% | ✓ BEAT |
Q3 2025 | Jul 24, 2025 | $0.19 | $0.26 | +36.8% | ✓ BEAT |
Q2 2025 | Apr 23, 2025 | $0.11 | $0.13 | +18.2% | ✓ BEAT |
Q1 2025 | Feb 19, 2025 | $0.29 | $0.27 | -6.9% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $0.22 | $0.35 | +59.1% | ✓ BEAT |
Q3 2024 | Jul 25, 2024 | $0.06 | $0.18 | +200.0% | ✓ BEAT |
Q2 2024 | Apr 25, 2024 | $0.10 | $0.15 | +50.0% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $0.10 | $0.17 | +70.0% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $0.21 | $0.35 | +66.7% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $0.17 | $0.26 | +52.9% | ✓ BEAT |
Q2 2023 | Apr 27, 2023 | $0.13 | $0.16 | +23.1% | ✓ BEAT |
Q1 2023 | Feb 22, 2023 | $0.15 | $0.19 | +26.7% | ✓ BEAT |
Q4 2022 | Oct 31, 2022 | $-0.01 | $-0.05 | -287.6% | ✗ MISS |
Q3 2022 | Jul 28, 2022 | $0.10 | $0.07 | -30.0% | ✗ MISS |
Q2 2022 | Apr 28, 2022 | $-0.05 | $-0.14 | -180.0% | ✗ MISS |
Q1 2022 | Feb 23, 2022 | $0.13 | $0.31 | +138.5% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $-0.14 | $-0.08 | +42.9% | ✓ BEAT |
Q3 2021 | Jul 27, 2021 | $-0.27 | $-0.12 | +55.6% | ✓ BEAT |
Latest News
Wells Fargo Maintains Overweight on Imax, Raises Price Target to $47
📈 PositiveJP Morgan Upgrades Imax to Overweight, Raises Price Target to $47
📈 PositiveWedbush Maintains Outperform on Imax, Raises Price Target to $46
📈 PositiveBenchmark Maintains Buy on Imax, Raises Price Target to $42
📈 PositiveBarrington Research Maintains Outperform on Imax, Raises Price Target to $42
📈 PositiveRosenblatt Maintains Buy on Imax, Raises Price Target to $47
📈 PositiveGKIDS And IMAX Expand Partnership To Bring Further 4K Studio Ghibli Restorations To North American Theaters In 2026 And Beyond
📈 PositiveIMAX ends day with 8% gains after sharing three-year targets at investor day
📈 PositiveImax shares are trading higher after the company provided outlook at its Investor Day.
📈 PositiveGoldman Sachs Upgrades Imax to Neutral, Raises Price Target to $34
➖ NeutralIMAX Prices $220M 0.75% Convertible Notes Due 2030 To Refinance 2026 Notes And Strengthen Balance Sheet
📈 PositiveIMAX To Offer $220M In Convertible Senior Notes Due 2030; $30M Upsize Option Included
➖ NeutralIMAX, Cinemark Sign Agreement To Launch New IMAX With Laser, IMAX 70mm Film Systems
📈 PositiveBarrington Research Maintains Outperform on Imax, Maintains $37 Price Target
📈 PositiveWells Fargo Maintains Overweight on Imax, Raises Price Target to $40
📈 PositiveJP Morgan Maintains Neutral on Imax, Raises Price Target to $32
➖ NeutralRosenblatt Maintains Buy on Imax, Maintains $42 Price Target
📈 PositiveBarrington Research Maintains Outperform on Imax, Maintains $37 Price Target
📈 PositiveImax Q3 Adj. EPS $0.47 Beats $0.38 Estimate, Sales $106.654M Beat $105.155M Estimate
📈 PositiveRoth Capital Maintains Buy on Imax, Raises Price Target to $40
📈 PositiveFrequently Asked Questions about IMAX
What is IMAX's current stock price?
What is the analyst price target for IMAX?
What sector is IMAX Corporation in?
What is IMAX's market cap?
Does IMAX pay dividends?
Similar Stocks
Communication Services SectorExplore stocks similar to IMAX for comparison